These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17149071)

  • 1. Thyroid status in patients with systemic sclerosis.
    Lippi G; Caramaschi P; Montagnana M; Salvagno GL; Volpe A; Guidi GC
    J Clin Rheumatol; 2006 Dec; 12(6):322-4. PubMed ID: 17149071
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-p53 antibodies in patients with systemic sclerosis.
    Mimura Y; Yazawa N; Tada Y; Ihn H; Tamaki K
    Int J Dermatol; 2007 May; 46(5):549-50. PubMed ID: 17472696
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet activation in patients with systemic scleroderma--pattern and significance.
    Agache I; Rădoi M; Duca L
    Rom J Intern Med; 2007; 45(2):183-91. PubMed ID: 18333373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum APRIL levels in patients with systemic sclerosis: distinct profiles of systemic sclerosis categorized by APRIL and BAFF.
    Matsushita T; Fujimoto M; Hasegawa M; Tanaka C; Kumada S; Ogawa F; Takehara K; Sato S
    J Rheumatol; 2007 Oct; 34(10):2056-62. PubMed ID: 17896803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum CXCL16 concentrations correlate with the extent of skin sclerosis in patients with systemic sclerosis.
    Yanaba K; Muroi E; Yoshizaki A; Hara T; Ogawa F; Shimizu K; Yozaki M; Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Rheumatol; 2009 Sep; 36(9):1917-23. PubMed ID: 19605674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is prevalence of PBC underestimated in patients with systemic sclerosis?
    Norman GL; Bialek A; Encabo S; Butkiewicz B; Wiechowska-Kozlowska A; Brzosko M; Shums Z; Milkiewicz P
    Dig Liver Dis; 2009 Oct; 41(10):762-4. PubMed ID: 19357001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on autoantibodies in systemic sclerosis.
    Walker JG; Fritzler MJ
    Curr Opin Rheumatol; 2007 Nov; 19(6):580-91. PubMed ID: 17917539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of the scleroderma phenotype in fibroblasts from systemic sclerosis patients.
    Qi Q; Guo Q; Tan G; Mao Y; Tang H; Zhou C; Zeng F
    J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):160-8. PubMed ID: 19054252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of serum hyaluronan levels in systemic sclerosis: association with disease severity.
    Yoshizaki A; Iwata Y; Komura K; Hara T; Ogawa F; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    J Rheumatol; 2008 Sep; 35(9):1825-9. PubMed ID: 18688912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum interleukin 23 in patients with systemic sclerosis.
    Komura K; Fujimoto M; Hasegawa M; Ogawa F; Hara T; Muroi E; Takehara K; Sato S
    J Rheumatol; 2008 Jan; 35(1):120-5. PubMed ID: 18085738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose UVA1 phototherapy for proximal and acral scleroderma in systemic sclerosis.
    Rose RF; Turner D; Goodfield MJ; Goulden V
    Photodermatol Photoimmunol Photomed; 2009 Jun; 25(3):153-5. PubMed ID: 19438995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic autoantibodies in systemic sclerosis.
    Gabrielli A; Svegliati S; Moroncini G; Avvedimento EV
    Curr Opin Immunol; 2007 Dec; 19(6):640-5. PubMed ID: 18083509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of stressful life events in patients with systemic sclerosis.
    Chen Y; Huang JZ; Qiang Y; Wang J; Han MM
    J Zhejiang Univ Sci B; 2008 Nov; 9(11):853-6. PubMed ID: 18988303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Low prevalence of anti-centromere antibodies in scleroderma in Morocco (about 272 cases)].
    Admou B; Arji N; Seghrouchni F; Missoum H; El Fenniri L; Amghar S; El Aouad R
    Ann Biol Clin (Paris); 2007; 65(3):291-7. PubMed ID: 17502303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localized scleroderma and systemic sclerosis: is there a connection?
    Gupta RA; Fiorentino D
    Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):1025-36. PubMed ID: 18068859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid function in systemic sclerosis.
    Tosti A; Peluso AM; Rapacchiale S; Urbini D; Bignami A; Giovanelli P; Cassani F; Bianchi FB
    J Endocrinol Invest; 1991 Oct; 14(9):783-4. PubMed ID: 1761815
    [No Abstract]   [Full Text] [Related]  

  • 17. High circulating levels of VEGF-C suggest abnormal lymphangiogenesis in systemic sclerosis.
    Chitale S; Al-Mowallad AF; Wang Q; Kumar S; Herrick A
    Rheumatology (Oxford); 2008 Nov; 47(11):1727-8. PubMed ID: 18820309
    [No Abstract]   [Full Text] [Related]  

  • 18. Comprehensive investigation of disease-specific short peptides in sera from patients with systemic sclerosis: complement C3f-des-arginine, detected predominantly in systemic sclerosis sera, enhances proliferation of vascular endothelial cells.
    Xiang Y; Matsui T; Matsuo K; Shimada K; Tohma S; Nakamura H; Masuko K; Yudoh K; Nishioka K; Kato T
    Arthritis Rheum; 2007 Jun; 56(6):2018-30. PubMed ID: 17530642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
    Simon D; Czömpöly T; Berki T; Minier T; Peti A; Tóth E; Czirják L; Németh P
    Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations of the findings regarding the relationship between N-terminal pro-brain natriuretic peptide and systemic sclerosis-related pulmonary arterial hypertension: comment on the article by Allanore et al.
    Dimitroulas T; Giannakoulas G; Karvounis H; Settas L
    Arthritis Rheum; 2008 Jul; 58(7):2215-6; author reply 2216. PubMed ID: 18576342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.